Vitamin B12 deficiency: correction of P-methylmalonic acid for estimated glomerular filtration rate to improve diagnostic value – a confirmatory study

References

• Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368(21):2041–2042.
   PubMedGoogle Scholar
• Hvas A, Nexo E. Diagnosis and treatment of vitamin B12 deficiency – an update. Haematologica. 2006;91(11):1506–1512.
   PubMed Web of Science ®Google Scholar
• Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood. 2005;105(3):978–985.
   PubMed Web of Science ®Google Scholar
• Devalia V, Hamilton MS, Molloy AM, et al. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513.
   PubMed Web of Science ®Google Scholar
• Carmel R. Diagnosis and management of clinical and subclinical cobalamin deficiencies: why controversies persist in the age of sensitive metabolic testing. Biochimie. 2013;95(5):1047–1055.
   PubMed Web of Science ®Google Scholar
• Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94(1):348–358.
   PubMed Web of Science ®Google Scholar
• Clarke R, Sherliker P, Hin H, et al. Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin. Clin Chem. 2007;53(5):963–970.
   PubMed Web of Science ®Google Scholar
• Goringe A, Ellis R, McDowell I, et al. The limited value of methylmalonic acid, homocysteine and holotranscobalamin in the diagnosis of early B12 deficiency. Haematologica. 2006;91(2):231–234.
   PubMed Web of Science ®Google Scholar
• Rajan S, Wallace JI, Beresford SA, et al. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc. 2002;50(4):624–630. Apr
   PubMed Web of Science ®Google Scholar
• Andres E, Affenberger S, Zimmer J, et al. Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency. Clin Lab Haematol. 2006;28(1):50–56.
   PubMedGoogle Scholar
• Zappacosta B, Persichilli S, Iacoviello L, et al. Folate, vitamin B12 and homocysteine status in an Italian blood donor population. Nutr Metab Cardiovasc Dis. 2013;23(5):473–480.
   PubMed Web of Science ®Google Scholar
• Herrmann W, Schorr H, Purschwitz K, et al. Total homocysteine, vitamin B(12), and total antioxidant status in vegetarians. Clin Chem. 2001;47(6):1094–1101.
   PubMed Web of Science ®Google Scholar
• Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603–2611.
   PubMed Web of Science ®Google Scholar
• Yetley EA, Pfeiffer CM, Phinney KW, et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr. 2011;94(1):313–321.
   PubMed Web of Science ®Google Scholar
• Vogiatzoglou A, Oulhaj A, Smith AD, et al. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 2009;55(12):2198–2206.
   PubMed Web of Science ®Google Scholar
• Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr. 1996;126(Suppl 4):1266–1272.
   Web of Science ®Google Scholar
• Morris MS, Jacques PF, Rosenberg IH, et al. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr. 2002;132(9):2799–2803.
   PubMed Web of Science ®Google Scholar
• Hvas AM, Juul S, Gerdes LU, et al. The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med. 2000;247(4):507–512.
   PubMed Web of Science ®Google Scholar
• Loikas S, Koskinen P, Irjala K, et al. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged. Clin Chem Lab Med. 2007;45(2):197–201.
   PubMed Web of Science ®Google Scholar
• Iqbal N, Azar D, Yun YM, et al. Serum methylmalonic acid and holotranscobalamin-II as markers for vitamin B12 deficiency in end-stage renal disease patients. Ann Clin Lab Sci. 2013;43(3):243–249.
   PubMed Web of Science ®Google Scholar
• Herrmann W, Schorr H, Geisel J, et al. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med. 2001;39(8):739–746.
   PubMed Web of Science ®Google Scholar
• van Loon SL, Wilbik AM, Kaymak U, et al. Improved testing for vitamin B12 deficiency: correcting MMA for eGFR reduces the number of patients classified as vitamin B12 deficient. Ann Clin Biochem. 2018;55(6):685–692.
   PubMed Web of Science ®Google Scholar
• Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr. 2003;77(5):1241–1247.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Danish Society of Nephrology, Paediatrics and Clinical Biochemistry. Chronic Kidney Disease: Analysis Methods and Clinical Evaluation; 2015 [accessed May 2, 2022]. Available from http://www.nephrology.dk/Publikationer/Kronisk%20nyresygdom%202015%20endelig,%2014-08-15.pdf
   Google Scholar
• Andrassy KM. Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;84(3):622–623.
   PubMed Web of Science ®Google Scholar
• Aarhus University Hospital, Table of Analyses for Clinical Biochemistry; 2022 [accessed May 2]. https://www.auh.dk/om-auh/afdelinger/blodprover-og-biokemi/Til-fagfolk/analysefortegnelsen/Biokemi/
   Google Scholar
• Harell FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. Heidelberg: Springer International Publishing; 2015.
   Google Scholar
• House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. Jama. 2010;303(16):1603–1609.
   PubMed Web of Science ®Google Scholar
• Heinz J, Kropf S, Domröse U, et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation. 2010;121(12):1432–1438.
   PubMed Web of Science ®Google Scholar
• Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163–1170.
   PubMed Web of Science ®Google Scholar
• Mann JF, Sheridan P, McQueen MJ, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease – results of the renal Hope-2 study. Nephrol Dial Transplant. 2007;23(2):645–653.
   PubMed Web of Science ®Google Scholar